Harvard Bioscience (HBIO) Gains from Investment Securities (2016 - 2026)
Harvard Bioscience (HBIO) reported Gains from Investment Securities of $16376.0 for Q1 2026, down 85.11% quarter-over-quarter from $110000.0 in Q4 2025.
Harvard Bioscience (HBIO) Gains from Investment Securities (2016 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has 11 years of Gains from Investment Securities data on file, last reported at $16376.0 in Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at $16376.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $16376.0 (up 102.21% YoY), and the FY2025 annual result was $16378.0, down 80.27% from the prior year.
- Gains from Investment Securities retreated to $16376.0 in Q1 2026 per HBIO's latest filing, from $110000.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $708793.0 in Q2 2025 and troughed at -$451000.0 in Q4 2023.
- A 5-year average of $51991.5 and a median of $54000.0 in 2023 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2023 and 2025: Gains from Investment Securities slumped 551.0% in 2023, then surged 4962.81% in 2025.
- A 5-year view of Gains from Investment Securities shows it stood at $100000.0 in 2022, then tumbled by 551.0% to -$451000.0 in 2023, then soared by 30.16% to -$315000.0 in 2024, then jumped by 134.92% to $110000.0 in 2025, then slumped by 85.11% to $16376.0 in 2026.
- Business Quant data shows HBIO's Gains from Investment Securities at $16376.0 in Q1 2026, $110000.0 in Q4 2025, and $166703.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Harvard Bioscience | 26.17 Mn | 19.07 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16,376.00 |
| Mar 31, 2026 | 16,376.00 |
| Dec 31, 2025 | 110,000.00 |
| Dec 31, 2025 | 110,000.00 |
| Sep 30, 2025 | 166,703.00 |
| Sep 30, 2025 | 166,703.00 |
| Jun 30, 2025 | 708,793.00 |
| Jun 30, 2025 | 708,793.00 |
| Dec 31, 2024 | -315,000.00 |
| Dec 31, 2024 | -315,000.00 |
| Sep 30, 2024 | 14,000.00 |
| Sep 30, 2024 | 14,000.00 |
| Jun 30, 2024 | 14,000.00 |
| Jun 30, 2024 | 14,000.00 |
| Mar 31, 2024 | 26,000.00 |
| Mar 31, 2024 | 26,000.00 |
| Dec 31, 2023 | -451,000.00 |
| Dec 31, 2023 | -451,000.00 |
| Sep 30, 2023 | 112,000.00 |
| Sep 30, 2023 | 112,000.00 |